Sumimoto R, Fukuda Y, Shinomiya T, Asahara T, Dohi K
Department of Surgery, Chugoku Rosai Hospital, Hiroshima, Japan.
Hiroshima J Med Sci. 1998 Jun;47(2):39-45.
We examined the appearance of DA type (RT1Aa) class I antigen in the serum of rats that had received isogeneic or allogeneic liver grafts (DA into DA, DA into LEW, PVG into DA, PVG into F1 hybrid (DAxPVG). Recipient LEW rats were given either one injection of the anti-CD8 mAb, OX-8, following thymectomy or anti-CD4 mAb (cocktail of OX-35 and OX-38) following thymectomy 3 days prior to liver grafting. We also tested the serum RT1Aa antigen titer of F1 (DAxPVG) recipients after PVG spleen transplantation and the serum RT1Aa antigen titer in the DA rat after hepatectomy and cyclosporin treatment. Replacement of DA liver by PVG lowered transiently the serum level of RT1Aa antigen to 70% of that in normal DA serum shortly after liver transplantation. However, this titer increased gradually over the level in normal DA serum. A PVG spleen graft to an F1 hybrid recipient resulted in death due to typical GVH disease between 13 and 24 days after spleen transplantation. The RT1Aa antigen titer increased to several times more than that in normal F1 serum throughout the observation period. LEW recipients of DA liver died at 9-11 days (9.8 +/- 1.1 days) due to acute liver rejection. In this combination, the serum level of RT1Aa increased until day 8, reaching a maximum (four times) on day 4. Deletion of either CD8+ or CD4+ T cells by anti-CD8 or anti-CD4 MAb in this transplantation prolonged the survival times of liver grafts for up to 26.8 +/- 8.4 and 35.6 +/- 17.9 days, respectively. In the anti-CD8 or anti-CD4 MAb- treated recipients, the serum titer of DA class I antigen was not elevated and there were no differences between the two. Hepatectomy in combination with cyclosporin induced a higher titer of liver-derived class I antigen in the serum as long as liver regeneration proceeded. These results suggest that the liver is the principal source of serum class I antigen in rats. Rejection, GVH reaction and liver regeneration increased the serum class I antigen from transplanted liver or host tissue. It is unlikely that this is due to cleavage of membranous class I antigen by class I- reactive CD8+ T cells.
我们检测了接受同基因或异基因肝移植的大鼠(DA 大鼠接受 DA 肝移植、DA 大鼠接受 LEW 肝移植、PVG 大鼠接受 DA 肝移植、PVG 大鼠接受 F1 杂交鼠(DA×PVG)肝移植)血清中 DA 型(RT1Aa)I 类抗原的出现情况。受体 LEW 大鼠在肝移植前 3 天胸腺切除后给予一次抗 CD8 单克隆抗体 OX - 8 注射,或胸腺切除后给予抗 CD4 单克隆抗体(OX - 35 和 OX - 38 的混合物)。我们还检测了 PVG 脾移植后 F1(DA×PVG)受体的血清 RT1Aa 抗原滴度以及肝切除和环孢素治疗后 DA 大鼠的血清 RT1Aa 抗原滴度。用 PVG 肝脏替代 DA 肝脏后,肝移植后不久血清中 RT1Aa 抗原水平暂时降至正常 DA 血清水平的 70%。然而,该滴度随后逐渐升高超过正常 DA 血清水平。将 PVG 脾移植到 F1 杂交受体后,在脾移植后 13 至 24 天因典型的移植物抗宿主病死亡。在整个观察期内,RT1Aa 抗原滴度增加至正常 F1 血清的数倍以上。接受 DA 肝脏的 LEW 受体在 9 - 11 天(9.8±1.1 天)因急性肝排斥反应死亡。在此组合中,血清中 RT1Aa 水平在第 8 天前升高,在第 4 天达到最高(四倍)。在该移植中,通过抗 CD8 或抗 CD4 单克隆抗体清除 CD8⁺或 CD4⁺T 细胞分别将肝移植的存活时间延长至 26.8±8.4 天和 35.6±17.9 天。在抗 CD8 或抗 CD4 单克隆抗体治疗的受体中,DA I 类抗原的血清滴度未升高,两者之间无差异。只要肝再生继续进行,肝切除联合环孢素会诱导血清中肝源性 I 类抗原的滴度升高。这些结果表明肝脏是大鼠血清 I 类抗原的主要来源。排斥反应、移植物抗宿主反应和肝再生会增加移植肝脏或宿主组织的血清 I 类抗原。这不太可能是由于 I 类反应性 CD8⁺T 细胞对膜 I 类抗原的裂解所致。